Also Known as Aurorix
Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
150mg
|
|||
Strength
300mg
|
Top Generic choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
150mg
|
|||
Strength
300mg
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Manerix (moclobemide) is a medication prescribed to treat depression and social phobia.
Manerix is available in 150 mg and 300 mg film-coated tablets for oral administration.
Fact Table | |
Formula | C13H17ClN2O2 |
License | Health Canada, EMA (Not FDA-approved) |
Bioavailability | ~55% (oral) |
Legal status | Prescription only (Rx) |
Chemical Name | 4-Chloro-N-(2-morpholin-4-ylethyl)benzamide |
Elimination half-life | 1–4 hours |
Dosage (Strength) | 150 mg, 300 mg (oral tablets) |
Pregnancy | Consult a doctor (Category C) |
Brands | Manerix |
Protein binding | 50% |
PubChem CID | 4234 |
MedlinePlus | Not available |
ChEBI | 6970 |
ATC code | N06AG02 |
DrugBank | DB01171 |
KEGG | D08206 |
Routes of administration | Oral |
Manerix should be taken as prescribed. Your doctor will determine an appropriate dosage and treatment regimen for you. The tablets should be taken at the end of a meal and should be swallowed with water.
Carefully read the medication guide for further usage instructions, including storage information.
Any questions or concerns may be referred to your doctor or pharmacist.
Moclobemide is the active ingredient in Manerix.
Lactose, maize starch, povidone K30, sodium starch glycollate, magnesium stearate, hypromellose, ethylcellulose, polyethylene glycol 6000, talc, and titanium dioxide (E171) are the inactive ingredients included. Yellow iron oxide (E172) is also included in the 150 mg tablets.
See the product label or ask your pharmacist for a full list of ingredients.
Manerix should not be given to patients who have any of the following:
Manerix side effects may include but are not limited to sleep problems; headache; dizziness; dry mouth; feeling sick; feeling nervous, anxious, restless, or irritable; tingling or numbness of your feet and hands; low blood pressure; sick; diarrhea; and constipation.
Immediately inform your doctor of any bothersome or persistent side effects you experience while taking Manerix.
Ask your doctor about Manerix.